Business
Directorate Change
Directorate Change.
About this update from Genedrive Plc
[{"type":"text","content":"\n\n \nTHIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED IN ARTICLE 7 OF REGULATION (EU) NO 596/2014 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL OF 16 APRIL 2014 ON MARKET ABUSE (MARKET ABUSE REGULATION) AS RETAINED AS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 AS AMENDED.\n \ngenedrive plc\n(\"genedrive\" or the \"Company\")\n \nDirectorate change\n \ngenedrive plc (AIM: GDR), the point of care pharmacogenetic testing company, announces that its Chief Executive Officer (\"CEO\"), James Cheek, has left the Company with immediate effect by mutual agreement.\n \nJames has been succeeded as CEO by Dr. Gino Miele PhD, currently Chief Scientific Officer (\"CSO\") who has been with the Company since 2011, serving as R&D Director and since September 2023 as CSO and an Executive Board Director. Prior to joining the Company Gino served as an Associate Director for clinical translational genomics at Wyeth and Pfizer.\n \nGino has been a key driver in the development of the genedrive instrumentation and products, positioning the Company at the forefront of pharmacogenomic testing in emergency healthcare settings and with the wider team has facilitated regulatory approval processes for the products throughout the UK, Europe and the Middle East. Gino was instrumental in the NICE approval processes for both the Genedrive® MT-RNR1 ID Kit and the Genedrive® CYP2C19 ID Kit, securing the Group's clinical trial agreement in the U.S., the recent FDA breakthrough device designation, and together with the genedrive commercial team is actively involved in generating a growing list of revenue opportunities in the UK and more widely. \n \nDr. Ian Gilham, Chairman of genedrive plc, said: \"Gino has an unparallelled knowledge and understanding of the Company, products and commercial strategies. I have every confidence that the leadership team, headed by Gino and strongly supported by our Chief Financial Officer, Russ Shaw, will lead genedrive to a successful future. I would like to thank James for his contributions at genedrive and, on behalf of the board, wish him well for the future.\"\n \nFor further details please contact:\n \n\n\n\n\ngenedrive plc\n\n\n+44 (0)161 989 0245\n\n\n\n\nGino Miele: CEO & CSO / Russ Shaw: CFO\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nPee...